Robert Toto, MD
Professor of Internal Medicine and Nephrology
Director, Clinical Nephrology
Director, Patient-Oriented Research in Nephrology
Richard E. Pratley, MD
Samuel E. Crockett Chair in Diabetes Research
Medical Director – AdventHealth Diabetes Institute
Senior Investigator and Diabetes Program Lead, AdventHealth Translational Research Institute
Adjunct Professor of Medicine, Johns Hopkins University School of Medicine
The case-based online activity will cover the treatment and management of patients with chronic and diabetic kidney disease.
This educational online activity is designed for US-based nephrologists and other healthcare professionals with an interest in treating patients with CKD, T2DM and CVD.
Upon the completion of this program, attendees should be able to:
- Specify the pathophysiological mechanisms underlying CKD that result in increased renal and CVD risks for patients with DKD
- Assess the roles of inflammation, fibrosis, and activation of MRs in the progression of CKD in patients with DKD
- Integrate evidence-based guideline screening assessments for CKD that may facilitate an earlier diagnosis of DKD into routine clinical practice
- Interpret data from clinical trials assessing the efficacy and safety of investigational renoprotective agents for the treatment of DKD
- Incorporate preventive measures to mitigate the risk of hyperkalemia in patients with DKD receiving MRA therapy
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group will designate each online meeting and simulcast for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with chronic and diabetic kidney disease.
CNE Credits: 1.0 ANCC Contact Hour.
CNE ACCREDITATION STATEMENT Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Robert Toto, MD Discloses that he worked as a Consultant for Boehringer-Ingelheim, Bayer, Reaata, Medscape, ACI, Vifor, AstraZeneca. He also received contracted research fees from NIH
Richard Pratley, MD Discloses that he has received Consulting fees from Corept Therapeutics Incorporated, Merck, Novo-Nordisk, Pfizer, Sanofi, Sochia Pharma Inc. and Sun Pharmaceutical Industries. He has also received research grant funding from Hanmi Pharmaceutical Co., Metavention, Novo-Nordisk, Poxel SA and Sanofi, and has been a paid speaker for Novo-Nordisk
CME Content Review
The content of this online activity was independently peer reviewed.
The reviewer of this online activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner
The reviewer of this activity has nothing to disclose
Staff, Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
Chris Drury, MA, MS, MBA, Medical Director for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Marissa Mays-Verman, Program Manager for Med Learning Group, has nothing to disclose.
Daniel Dasilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the online activity.
- Complete the online post-test and evaluation.
You will receive your certificate as a downloadable file.
Med Learning Group makes every effort to develop CME activities that are science based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at firstname.lastname@example.org
RELEASE DATE: October 14, 2021
EXPIRATION DATE: October 14, 2022
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at email@example.com
Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.